Advertisement
News
Subscribe to MDT Magazine News

Dose optimization workshop helps reduce radiation dose associated with MDCT scans

August 2, 2010 9:41 am | by EurekAlert | Comments

(American College of Radiology / American Roentgen Ray Society) Numerous radiology practices were able to significantly reduce the radiation dose associated with multi-detector computed tomography scans by participating in a one day dose optimization workshop provided by the Royal...

TOPICS:

Insights from SUSS workshop on thin wafer handling at Semicon'West 2010

August 2, 2010 9:40 am | by I-Micronews | Comments

At the recent Semicon exhibition in San Francisco Suss assembled a group of partners and technical and market experts (shown below) to discuss the status of 3D IC and specifically temporary bonding and thin wafer handling.

RoundTable Healthcare Partners Portfolio Company, Aspen Surgical Products, Inc., Acquires Bard-Parker™ Surgical Blades and Scalpels Business

August 2, 2010 9:38 am | by Bio-Medicine.Org | Comments

LAKE FOREST, Ill. , Aug. 2 /- RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that its portfolio company, Aspen Surgical Products, Inc. (" Aspen "), has acquired the Bard-Parker...

TOPICS:
Advertisement

Haemonetics 1Q profit slips but tops expectations

August 2, 2010 7:45 am | by The Associated Press | Comments

Blood collection and processing systems maker Haemonetics Corp. said Monday its net income dipped 1 percent in the fiscal first quarter but still topped Wall Street expectations as strong sales of platelet disposables offset a decline in its plasma business.Haemonetics said earnings slipped to...

LifePoint Hospitals 2Q earnings climb 43 percent

August 2, 2010 6:45 am | by The Associated Press | Comments

Rural hospital operator LifePoint Hospitals Inc. said Monday its second-quarter net income climbed 43 percent compared to last year, when rising expenses helped knock down earnings.The Brentwood, Tenn., company said it earned $37.6 million, or 69 cents per share, in the three months that ended...

Stocks start month with big gains

August 2, 2010 6:45 am | by STEPHEN BERNARD - AP Business Writer - Associated Press | Comments

Stocks kicked off the new month with a big gain Monday, after strong manufacturing reports around the world and upbeat earnings added to hopes that the global recovery is picking up pace.The Dow Jones industrial average jumped almost 175 points. Broader indexes also rose nearly 2 percent.The...

BD Completes Sales of Ophthalmic Systems Unit and Surgical Blades Product Platform

August 2, 2010 6:38 am | by Bio-Medicine.Org | Comments

FRANKLIN LAKES, N.J. , Aug. 2 /- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced the completion of the sale of its Ophthalmic Systems unit to RoundTable Healthcare Partners and the sale of its surgical blades product platform...

TOPICS:

FDA Approves Merz Pharmaceuticals' Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm

August 2, 2010 6:37 am | by Bio-Medicine.Org | Comments

GREENSBORO, N.C. , Aug. 2 /- Merz Pharmaceuticals today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin ® (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm. According to...

TOPICS:
Advertisement

OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year

August 2, 2010 6:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO , Aug. 2 /- Novalar Pharmaceuticals, Inc., a specialty pharmaceutical company focused in dental, today announced that OraVerse®, the company's premier pharmaceutical product, has again been selected by leading dental industry magazine Dentistry Today as one of its 'Top 100...

TOPICS:

Cornerstone Therapeutics Announces Collaboration with The Cough Company

August 2, 2010 6:34 am | by Bio-Medicine.Org | Comments

CARY, N.C. , Aug. 2 /- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) ("Cornerstone" or the "Company"), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that the...

TOPICS:

Georgia Tech Awarded a $20M Center for Chemical Innovation

August 2, 2010 6:33 am | by Georgia Tech Institute of Technology | Comments

A team of institutions led by Georgia Tech has been awarded $20 million from the National Science Foundation and National Aeronautics and Space Administration to pursue research that could lead to a better understanding of how life started on Earth.

TOPICS:

HealthSouth returns to 2Q profit, boosts view

August 2, 2010 5:45 am | by The Associated Press | Comments

HealthSouth Corp., which provides inpatient rehabilitation services, said Monday posted a profit for the second quarter compared to a loss a year ago, when a securities litigation settlement dragged down performance.CEO Jay Grinney said the company's latest results were helped by good volume...

Henry Schein 2Q net income rises 15 percent

August 2, 2010 4:45 am | by The Associated Press | Comments

Device maker Henry Schein Inc. said Monday its second-quarter profit rose 15 percent on a boost in dental and animal health sales in North America.The company earned $84 million, or 90 cents per share, up from $73.5 million, or 81 cents per share, during the same period a year prior. Revenue...

BioElectronics Expands Clinical Research in Four Key Categories

August 2, 2010 4:45 am | by The Associated Press | Comments

BioElectronics (PINKSHEETS: BIEL) filed four applications for grants in order to conduct clinical studies on Diabetic Neuropathic Foot Ulcers, Oral Surgery Pain, Plantar Fasciitis, and Menstrual Pain. Upon completion of the studies, the data will be used for U.S. FDA submissions to gain...

TOPICS:

Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon Programs

August 2, 2010 3:36 am | by Bio-Medicine.Org | Comments

THE WOODLANDS, Texas , Aug. 2 /- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today announced that it has exercised a restructured purchase option under its drug development...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading